1. The signaling pathway of stromal cell-derived factor-1 and its role in kidney diseases
   Song Mao et al, 2014, Journal of Receptors and Signal Transduction CrossRef
2. Chemokines and Bone
   Annette Gilchrist et al, 2015, Clinical Reviews in Bone and Mineral Metabolism CrossRef
3. Clinicopathological and prognostic significance of CXCR4 high expression in renal cell carcinoma: A meta-analysis and literature review
   Xiaosan Si et al, 2019, International Journal of Surgery CrossRef
4. Development of a novel 99mTc‐labeled small molecular antagonist for CXCR4 positive tumor imaging
   Xuran Zhang et al, 2018, Journal of Labelled Compounds and Radiopharmaceuticals CrossRef
5. The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer
   TIAN-BAO WANG et al, 2014, International Journal of Oncology CrossRef
6. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
   Ashraf Mousavi, 2020, Immunology Letters CrossRef
7. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma
   Yang Dong et al, 2021, BMC Cancer CrossRef
8. Inflammation in Urological Malignancies: The Silent Killer
   Martina Catalano et al, 2023, International Journal of Molecular Sciences CrossRef
9. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
   Giovanni Luca Gravina et al, 2015, The Prostate CrossRef
10. Pathological roles of the homeostatic chemokine CXCL12
    Rik Janssens et al, 2018, Cytokine & Growth Factor Reviews CrossRef
11. RNA interference in organ transplantation: next-generation medicine?
    Isabel M.A. Brüggenwirth et al, 2021, Organ Repair and Regeneration CrossRef
12. Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells
    Zhi-xiang Yuan et al, 2016, Frontiers in Pharmacology CrossRef
13. Structural Guided Scaffold Phage Display Libraries as a Source of Bio-Therapeutics
    Y. K. Stella Man et al, 2013, PLoS ONE CrossRef
14. The Intricate Role of CXCR4 in Cancer
    Samit Chatterjee et al, 2014, Emerging Applications of Molecular Imaging to Oncology CrossRef
15. The Role of Inflammation in Kidney Cancer
    Antonio Roma de Vivar Chevez et al, 2014, Inflammation and Cancer CrossRef
16. MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway
    Wei Yuan et al, 2016, Oncotarget CrossRef
17. Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer
    Q Yang et al, 2014, British Journal of Cancer CrossRef
18. Clinicopathological Significance of CXCR4 Expression in Renal Cell Carcinoma: A Meta-Analysis
    Bo Tang et al, 2015, Annals of Surgical Oncology CrossRef
19. The Role of CXCL12 in Kidney Diseases: A Friend or Foe?
    Anni Song et al, 2021, Kidney Diseases CrossRef
20. Targeting Strategies for Renal Cancer Stem Cell Therapy
    Pengchao Fang et al, 2020, Current Pharmaceutical Design CrossRef
21. Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer
    Jia Li et al, 2014, BMB Reports CrossRef
22. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma
    Yozo Mitsui et al, 2017, Molecular Cancer Research CrossRef
23. Retracted: Impaired Th17 cell proliferation and decreased pro‐inflammatory cytokine production in CXCR3/CXCR4 double‐deficient mice of vulvovaginal candidiasis
    Yue‐Mei Jin et al, 2019, Journal of Cellular Physiology CrossRef